Congxiao Zhang

Congxiao Zhang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
ZMZhangyu Ma
Zhangyu Ma
XZXingyu Zhao
Xingyu Zhao
JZJing Zhao
Jing Zhao
ZZZhilong Zhao
Zhilong Zhao
QWQihui Wang
Qihui Wang
CZCongxiao Zhang
Congxiao Zhang
Polyether ether ketone (PEEK) is a non-toxic polymer with elastic modulus close to human bone. Compared with metal implants, PEEK has advantages such as evasion of stress shielding effect, easy processing, and similar color as teeth, among others. Therefore, it is an excellent substitute material for titanium dental orthopedic implants. However, PEEK’s biological inertia limits its use as an implant. To change PEEK’s biological inertia and increase its binding ability with bone tissue as an implant, researchers have explored a number of modification methods to enhance PEEK’s biological activities such as cellular compatibility, osteogenic activity, and antibacterial activity. This review summarizes current biological activity modification methods for PEEK, including surface modification and blending modification, and analyzes the advantages and disadvantages of each modification method. We believe that modified PEEK will be a promising dental and orthopedic implant material.

17 December 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ZZZhilong Zhao
Zhilong Zhao
DLDan Li
Dan Li
ZWZiqi Wu
Ziqi Wu
QWQihui Wang
Qihui Wang
ZMZhangyu Ma
Zhangyu Ma
CZCongxiao Zhang
Congxiao Zhang
Oral cancers refer to malignant tumors associated with high morbidity and mortality, and oral squamous cell carcinoma accounts for the majority of cases. It is an important part of head and neck, and oral cancer is one of the six most common cancers in the world. At present, the traditional treatment methods for oral cancer include surgery, radiation therapy, and chemotherapy. However, these methods have many disadvantages. In recent years, nanomedicine, the delivery of drugs through nanoplatforms for the treatment of cancer, has become a promising substitutive therapy. The use of nanoplatforms can reduce the degradation of the drug in the body and accurately deliver it to the tumor site. This minimizes the distribution of the drug to other organs, thereby reducing its toxicity and allowing higher drug concentration at the tumor site. This review introduces polymer nanoparticles, lipid-based nanoparticles, metal nanoparticles, hydrogels, exosomes, and dendrimers for the treatment of oral cancer, and discusses how these nanoplatforms play an anti-cancer effect. Finally, the review gives a slight outlook on the future prospects of nanoplatforms for oral cancer treatment.

11 January 2021 in Frontiers in Materials
Verified
Journal Article
Open access
PDF file
ZZZhilong Zhao
Zhilong Zhao
QWQihui Wang
Qihui Wang
JZJing Zhao
Jing Zhao
BZBo Zhao
Bo Zhao
ZMZhangyu Ma
Zhangyu Ma
CZCongxiao Zhang
Congxiao Zhang
Dental bonding materials are widely used in dentistry and there are several available kinds. However, in recent years, there has been no further research into dental bonding materials, with most dentists focusing on dental implants and orthodontics. In this paper, we systematically review the technology of tooth bonding in recent years and summarize the existing literature for potential innovation and direction of future research. First, the theoretical research on dental assembly materials and bonding mechanism was reviewed. Then, we reviewed the bonding of teeth, the bonding of metal alloy prosthesis, and the measurement of bond strength. Finally, the future development of dental bonding technology was evaluated. It is hoped that more dentists will be able to treat patients and update research on bonding materials in the field of teeth bonding to bring a new era to the restoration of teeth in the future.

1 February 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YWYuqian Wang
Yuqian Wang
ZZZhilong Zhao
Zhilong Zhao
CLChenlu Liu
Chenlu Liu
MHMiao Hao
Miao Hao
CKChenfei Kong
Chenfei Kong
JJJinlan Jiang
Jinlan Jiang
Introduction: Coating of nanomedicine with cell membranes has attracted increasing attention as it can boost biocompatibility and improve the efficiency of treatment. Herein, we prepared innovative tumor cell-membrane-coated vesicles based on photodynamic therapy (PDT) drug indocyanine green (ICG) and explore the effect on melanoma in vitro and in vivo. Methods: ICG was coated with B16 cell membranes ([email protected] NVs) by sonication and extrusion, and the morphological characteristics of [email protected] NVs were evaluated by transmission electron microscopy (TEM) and NP-tracking analysis. Homologous cellular uptake was evaluated by flow cytometry (FCM) after staining by DiD dye. Cellular cytotoxicity was evaluated by cell counting kit-8 assay and the anti-tumor effect in vitro was assessed by FCM and western blotting. The anti-tumor effect in vivo was evaluated in a B16 xenograft model in mice. The tumor micro-environment was investigated by FCM and real-time PCR. Results: The vesicles are stable and uniform in nature, and show strong homologous targeting in vivo and in vitro. The vesicles can generate reactive oxygen species to induce apoptosis of B16 cells under near-infrared irradiation. Furthermore, the [email protected] NVs induce a significant anti-tumor response in vivo, and perform better with respect to both tumor growth inhibition and lifespan extension. Analysis of immunocytes in the tumor microenvironment showed significant reductions in numbers of myeloid-derived suppressor cells and tumor-associated M2 macrophages in mice in the [email protected] NVs group. This was accompanied by significant increases in numbers of M1 macrophages and proliferative CD4+/CD8+ T cells. Expression levels of IFN-γ and IL-2 increased in the [email protected] NVs group, while expression of TGF-β and IL-10 decreased. Conclusion: The results show that the [email protected] NVs are feasible drugs for the treatment of melanoma by inducing cell apoptosis under NIR and shifting the immunosuppressive tumor microenvironment in vivo. Graphical Abstract:

3 January 2025 in Advanced Science
Verified
Journal Article
Open access
QWQihui Wang
Qihui Wang
GWGuoliang Wang
Guoliang Wang
XLXinru Li
Xinru Li
DLDi Li
Di Li
CZCongxiao Zhang
Congxiao Zhang
Jianxun DingJianxun Ding
Jianxun Ding
Dentin hypersensitivity (DH), marked by exposed dentinal tubules, presents as a sharp toothache triggered by stimuli and subsides when the stimuli are removed. To address the limitations of current commercial desensitizers in terms of acid resistance, friction resistance, and stability, a black phosphorus nanosheet‐composited methacrylate gelatin hydrogel (GelMA/BP) is developed for DH treatment, leveraging the synergistic effects of photothermal therapy and biomineralization. Incorporating the BP nanosheet provided GelMA/BP with a stable photothermal response and the continuous release of phosphate anions, which blocked dentinal tubules by converting light energy into heat and initiating biomineralization. In vitro desensitizing therapy showed that the dentinal tubule diameter in the GelMA/BP50 group (0−1.13 µm) is significantly reduced compared to that in the DH‐model group (0−3.14 µm). The GelMA/BP50 group achieved an 86% tubule occlusion rate, with acid resistance of 80%, friction resistance of 76%, and long‐term stability of 74%. In vivo studies further validated the efficacy of GelMA/BP50, showing a reduction in tubule diameter (0−0.37 µm) and an occlusion rate of 79%, which alleviated toothache and increased intake and weight. These results demonstrate that this desensitizing hydrogel acts as an effective dentinal tubule sealant, offering promising clinical benefits for the topical treatment of DH.

26 December 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
YXYimei Xu
Yimei Xu
YQYaxuan Qu
Yaxuan Qu
CZCongxiao Zhang
Congxiao Zhang
CNCanyang Niu
Canyang Niu
XTXiaowen Tang
Xiaowen Tang
KWKewei Wang
Kewei Wang
The temperature-sensitive Ca2+-permeable TRPV3 ion channel is robustly expressed in the skin keratinocytes, and its gain-of-function mutations are involved in the pathology of skin lesions. Here, we report the identification of an antispasmodic agent flopropione that alleviates skin inflammation by selective inhibition of TRPV3. In whole-cell patch clamp recordings, flopropione selectively inhibits macroscopic TRPV3 currents in a concentration-dependent manner with an IC50 value of 17.8 ± 3.5 μM. At the single-channel level, flopropione inhibits TRPV3 channel open probability without alteration of its unitary conductance. In an in vivo mouse model of skin inflammation induced by the skin sensitizer DNFB, flopropione also alleviates dorsal skin lesions and ear skin swelling. Further molecular docking combined with site-directed mutagenesis reveals that two residues E501 and I505 in the channel S2-helix are critical for flopropione-mediated inhibition of TRPV3. Taken together, our findings demonstrate that the spasmolytic drug flopropione as a selective inhibitor of TRPV3 channel not only provides a valuable tool molecule for understanding of TRPV3 channel pharmacology but also holds repurposing potential for therapy of skin disorders, such as dermatitis and pruritus.